Ticker Launch
Sign inTry it free

SPAC · Deal announced · ASPC

ASPAC III Acquisition Corp.

Business combination with Bioserica International Limited

ASPAC III Acquisition Corp. (ASPC) is a blank-check company (SPAC) that raised $55M in its initial public offering on Nov 8, 2024. It agreed to combine with Bioserica International Limited, announced on Jan 24, 2025, at a stated value of $200M. The deal has not closed yet. Loeb & Loeb advised the SPAC and Ellenoff Grossman & Schole advised the underwriters on the IPO.

Research, manufacture and sale of bio-based antimicrobial materials

Status
Deal announced
Ticker
ASPC
IPO date
Nov 8, 2024
IPO size
$55M
Target
Bioserica International Limited
Target sector
Industrial
Announced
Jan 24, 2025
Stated deal value
$200M
Combined company
A SPAC III Mini Acquisition Corp. (Purchaser/PubCo)
SPAC counsel (IPO)
Loeb & Loeb and Ogier
Underwriters' counsel (IPO)
Ellenoff Grossman & Schole

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other pending SPAC mergers